在亚洲NAFLD患者中用优化Baveno VI弹性成像界值筛查代偿期进展性慢性肝病
该研究在830例经活检证实的亚洲NAFLD患者中验证8/12 kPa双界值及Papatheodoridi算法识别cACLD的性能;新界值较原10/15 kPa特异性相当而敏感性更高,联合简化风险模型的两步筛查使分类率从73.5%提升至86.7%。
要点
- 8/12 kPa双界值较原10/15 kPa特异性相当、敏感性更高,更适合亚洲NAFLD人群。
- 简化风险模型(年龄、肝硬度值、血小板计数)优于单用肝硬度测量。
- 两步筛查使分类率从73.5%升至86.7%,假阴性率低于Papatheodoridi算法。
核心结论
- 8/12 kPa双弹性成像界值更适合识别亚洲NAFLD患者的cACLD。
- 对未分类患者联合简化风险模型的两步法分类率约85%。
研究设计与样本
- 纳入830例经活检证实的NAFLD患者,使用瞬时弹性成像(FibroScan)测量肝硬度。
- 在三个人群特征明确的亚洲NAFLD队列中验证8/12 kPa双界值及Papatheodoridi算法。
主要发现
- cACLD占21.8%。
- 新界值较原Baveno VI 10/15 kPa特异性相当、敏感性更高。
- 简化风险模型含年龄、肝硬度值、血小板计数,在两个中国队列中优于单用肝硬度测量(P=0.001),并在马来西亚队列中验证(P=0.04)。
- 两步筛查分类率从原双界值的73.5%提升至86.7%。
- 简化风险模型假阴性率显著低于Papatheodoridi优化筛查法(27.1% vs 41.4%;P=0.01)。
关键数值与推荐
- 双弹性成像界值为8/12 kPa。
- 原Baveno VI弹性成像界值为10/15 kPa。
- 简化风险模型包含年龄、肝硬度值、血小板计数。
临床怎么用
- 在亚洲NAFLD患者中可采用8/12 kPa双界值筛查cACLD。
- 对双界值未分类患者可联合年龄、肝硬度值、血小板计数的简化风险模型进行两步筛查。
局限性
- 研究人群为亚洲NAFLD患者,结论外推需谨慎。
- 验证队列包括两个中国队列和一个马来西亚队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recently, Papatheodoridi et al proposed to refine the Baveno VI elastography dual-cutoffs and introduce an algorithm for the detection of compensated advanced chronic liver disease (cACLD) in asymptomatic European patients with chronic liver diseases. AIMS: To validate the performance of the dual-cutoffs (8/12 kPa) and the proposed algorithm to identify patients with cACLD in three well-characterised Asian nonalcoholic fatty liver disease (NAFLD) cohorts. METHODS: We included 830 patients with biopsy-proven NAFLD. Liver stiffness was measured using transient elastography (FibroScan). RESULTS: cACLD was found in 21.8% of patients. Compared with the original Baveno VI elastography criteria (10/15 kPa), the new cutoffs showed a comparable specificity and a higher sensitivity for identifying cACLD. We developed a simplified risk model incorporating age, liver stiffness value, and platelet count, which outperformed liver stiffness measurement alone in two Chinese cohorts (P = 0.001), and was further validated in a Malaysian cohort (P = 0.04). Overall, the "two-step" screening of cACLD improved classification rates from 73.5% by the original dual-cutoffs to 86.7%. Notably, usage of our simplified risk model resulted in significantly lower false-negative rate than the refined screening approach by Papatheodoridi et al (27.1% vs 41.4%; P = 0.01). CONCLUSIONS: The dual elastography cutoffs of 8 and 12 kPa are more appropriate to identify cACLD in Asian patients with NAFLD. In combination with a simplified risk model in unclassified patients, the two-step approach showed a classification rate of about 85%.
引用
- Zhou YJ, Gao F, Liu WY, et al. Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2021. PMID: 34152626. doi:10.1111/apt.16487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。